Login / Signup

Matters arising: In vivo effects of the alpha-synuclein misfolding inhibitor minzasolmin supports clinical development in Parkinson's disease.

Michel Alexander Steiner
Published in: NPJ Parkinson's disease (2024)
Keyphrases
  • rare case